Literature DB >> 10532535

Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway".

Y Sano1, J W Streilein, B R Ksander.   

Abstract

BACKGROUND: The immune mechanisms by which corneal allografts are rejected in normal ocular graft beds have not been identified. Both acceptors and rejectors of these types of grafts display donor-specific delayed hypersensitivity and in vitro proliferating primed T cells, yet neither develop conventional, donor-specific cytotoxic T cells. We wished to determine whether unconventional donor-specific cytotoxic T cells are generated in rejector mice that recognize donor minor alloantigens presented by recipient major histocompatibility complex (MHC) molecules.
METHODS: BALB/c mice received orthotopic corneal allografts from C57BL/10 donors in normal eyes. At 4 weeks (when 50% of grafts can be designated as rejected), primed cytotoxic T lymphocyte (CTL) activity in draining lymph nodes and spleen was assayed on targets selected to present donor-type minor H antigens on recipient MHC molecules. Control mice received heterotopic corneal allografts and were similarly examined.
RESULTS: Lymphoid organs of recipients that rejected orthotopic or heterotopic corneal allografts contained CTL that lysed targets expressing donor-type minor H antigens presented by recipient MHC molecules. By contrast, no CTL activity was detected from lymphoid cells of recipients that accepted orthotopic corneal allografts. Rejection of orthotopic corneal allografts placed into normal mouse eyes correlates directly with the generation of donor-specific CTL that recognize minor H antigens in the context of recipients MHC molecules.
CONCLUSIONS: These results indicate the indirect pathway of alloantigen presentation is the only pathway operative in the process by which orthotopic corneal allografts are rejected. The roles of emigrant Langerhans cells and corneal lymphatics in the indirect pathway are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10532535     DOI: 10.1097/00007890-199910150-00011

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

Review 1.  Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells.

Authors:  Takaaki Hattori; Hiroki Takahashi; Reza Dana
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

Review 2.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

3.  Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation.

Authors:  Marko Pastak; Veronika Kleff; Daniel R Saban; Marta Czugala; Klaus-Peter Steuhl; Süleyman Ergün; Bernhard B Singer; Thomas A Fuchsluger
Journal:  Hum Gene Ther       Date:  2017-10-06       Impact factor: 5.695

Review 4.  High-risk corneal allografts: A therapeutic challenge.

Authors:  Tian Yu; Vijayalakshmi Rajendran; May Griffith; John V Forrester; Lucia Kuffová
Journal:  World J Transplant       Date:  2016-03-24

5.  Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation.

Authors:  Takaaki Hattori; Daniel R Saban; Parisa Emami-Naeini; Sunil K Chauhan; Toshinari Funaki; Hiroki Ueno; Reza Dana
Journal:  J Leukoc Biol       Date:  2012-01-30       Impact factor: 4.962

6.  Quantitative evaluation of the corneal endothelium in the mouse after grafting.

Authors:  J Plskova; L Kuffova; M Filipec; V Holan; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

Review 7.  Alloimmunity and Tolerance in Corneal Transplantation.

Authors:  Afsaneh Amouzegar; Sunil K Chauhan; Reza Dana
Journal:  J Immunol       Date:  2016-05-15       Impact factor: 5.422

8.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).

Authors:  Reza Dana
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 9.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

10.  The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens.

Authors:  Daniel R Saban; Janet Cornelius; Sharmila Masli; Johannes Schwartzkopff; Maire Doyle; Sunil K Chauhan; Ammon B Peck; Maria B Grant
Journal:  Mol Vis       Date:  2008-12-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.